New fertility drug dose aims for safer, faster pregnancies

NCT ID NCT07153367

Recruiting now Disease control Sponsor: Centre Hospitalier Intercommunal Creteil Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 25 times

Summary

This study is for women with regular cycles who are trying to get pregnant through intrauterine insemination (IUI). Researchers want to see if a fixed, low dose of the hormone follitropin delta can stimulate the ovaries to produce two mature eggs, boosting pregnancy chances while lowering the risk of twins or triplets. The goal is to make the first IUI attempt more effective and comfortable.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Cabinet Dr Elodie Descat-Polyclinique Jean Villar
RECRUITING

Bruges, 33520, France

Contact Email: •••••@•••••

Contact
Cabinet Dr Géraldine PORCU-Institut de Médecine de la Reproduction
RECRUITING

Marseille, 13008, France

Contact Email: •••••@•••••

Contact
Cabinet Dr Nathalie Massin- Hôpital Américain De Paris
SUSPENDED

Neuilly-sur-Seine, 92200, France
Cabinet Dr Nicolas Chevalier-Centre AMP Saint Roch
RECRUITING

Montpellier, 34070, France

Contact Email: •••••@•••••

Contact
Chi Creteil
RECRUITING

Créteil, 94000, France

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Conditions

Explore the condition pages connected to this study.

INFERTILITY INSEMINATION